Compare EXAS & EXPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXAS | EXPD |
|---|---|---|
| Founded | 1995 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 19.6B |
| IPO Year | 2000 | 1995 |
| Metric | EXAS | EXPD |
|---|---|---|
| Price | $103.89 | $147.49 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 17 | 10 |
| Target Price | $86.62 | ★ $131.90 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.06% |
| EPS Growth | ★ 80.32 | 4.02 |
| EPS | N/A | ★ 5.95 |
| Revenue | $4,144,000.00 | ★ $6,920,948,000.00 |
| Revenue This Year | $15.37 | $2.70 |
| Revenue Next Year | $12.41 | $3.75 |
| P/E Ratio | ★ N/A | $24.24 |
| Revenue Growth | N/A | ★ 13.49 |
| 52 Week Low | $38.88 | $100.47 |
| 52 Week High | $104.02 | $167.19 |
| Indicator | EXAS | EXPD |
|---|---|---|
| Relative Strength Index (RSI) | 61.72 | 51.19 |
| Support Level | $103.10 | $137.00 |
| Resistance Level | N/A | $148.97 |
| Average True Range (ATR) | 0.31 | 3.41 |
| MACD | -0.03 | 0.62 |
| Stochastic Oscillator | 86.96 | 89.12 |
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
Based in the US, Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. Expeditors derives around 35% of consolidated gross revenue from airfreight, 30% from ocean freight, and 36% from customs brokerage and other services.